Skip to content

Main article: Delivering 3 X 5: what are the next steps?

Level of compensation for people infected with HCV during NHS treatment announced

Ritonavir price increase: Abbott no longer welcome in our offices, say 34 leading HIV docs

AZT resistance and vertical transmission not seen since revised 1998 BHIVA guidelines

French HIV-2 cohort study: treat only when plasma viral load can be measured.

Atazanavir shown to boost amprenavir levels

Swiss close to introducing voluntary HIV tests for asylum seekers

Are WHO and Global Fund supporting sub-standard malaria treatment?

Once-daily topical tablet as effective as systemic drugs for oral thrush

Rapid HIV tests should be used on women in labour

Call to make HIV and sexual health key UK health priorities

Gilead abandons research on salvage drug

Saunas and drugs linked with rectal gonorrhoea in gay men in San Francisco study

New formulation of nelfinavir clears key hurdle on road to EU approval

Meta-analysis finds PI-based HAART better than NNRTI regimens in NRTI experienced

Vatican accuses drug companies of genocide

New warning about nevirapine liver toxicities issued by manufacturer

Three-fold increase in new HIV cases amongst UK Caribbeans between 1997 - 2001